Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 14, Supplement A, 1984   [Index by Author] 


Down List of Abbreviations
Down Introduction
Down Section I. Some Less Well-Emphasized Considerations in the Development of Antivirals
Down Section II. Clinical Studies with Newer Anti-Herpes Compounds
Down Section III. Experimental and Laboratory Studies
Down Section IV. Future Prospects
Down Index


[Search ALL Issues]

Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

List of Abbreviations Back

List of abbreviations
J. Antimicrob. Chemother. 1984 14: v; doi:10.1093/jac/14.suppl_A.v [PDF] [Request Permissions]  

Introduction Back

J. S. Oxford and H. J. Field
Introduction: a virological prescript
J. Antimicrob. Chemother. 1984 14: 1-4; doi:10.1093/jac/14.suppl_A.1 [PDF] [Request Permissions]  

Section I. Some Less Well-Emphasized Considerations in the Development of Antivirals Back

B. Öberg and N.-G. Johansson
The relative merits and drawbacks of new nucleoside analogues with clinical potential
J. Antimicrob. Chemother. 1984 14: 5-26; doi:10.1093/jac/14.suppl_A.5 [Abstract] [PDF] [Request Permissions]  

Peter G. Canonico, Meir Kende, Bruno J. Luscri, and John W. Huggins
In-vivo activity of antivirals against exotic RNA viral infections
J. Antimicrob. Chemother. 1984 14: 27-41; doi:10.1093/jac/14.suppl_A.27 [Abstract] [PDF] [Request Permissions]  

D. C. Kelly
Baculovirus replication: effects of inhibitors of macromolecular synthesis
J. Antimicrob. Chemother. 1984 14: 43-55; doi:10.1093/jac/14.suppl_A.43 [Abstract] [PDF] [Request Permissions]  

Section II. Clinical Studies with Newer Anti-Herpes Compounds Back

Richard J. Whitley
Treatment of human herpesvirus infections with special reference to encephalitis
J. Antimicrob. Chemother. 1984 14: 57-74; doi:10.1093/jac/14.suppl_A.57 [PDF] [Request Permissions]  

A. Mindel
Treatment and prevention of herpes genital infection
J. Antimicrob. Chemother. 1984 14: 75-83; doi:10.1093/jac/14.suppl_A.75 [Abstract] [PDF] [Request Permissions]  

Section III. Experimental and Laboratory Studies Back

Erik De Clercq
The antiviral spectrum of (E)-5-(2-bromovinyl)-2 '-deoxyuridine
J. Antimicrob. Chemother. 1984 14: 85-95; doi:10.1093/jac/14.suppl_A.85 [Abstract] [PDF] [Request Permissions]  

Margaret Tisdale and J. W. T. Selway
Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B
J. Antimicrob. Chemother. 1984 14: 97-105; doi:10.1093/jac/14.suppl_A.97 [Abstract] [PDF] [Request Permissions]  

M. A. Gray and C. A. Pasternak
‘Impermeant’ inhibitors of protein synthesis do not affect virally-infected cells as a result of a permeability change
J. Antimicrob. Chemother. 1984 14: 107-110; doi:10.1093/jac/14.suppl_A.107 [Abstract] [PDF] [Request Permissions]  

I. S. Sim
Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2 '-deoxyuridine
J. Antimicrob. Chemother. 1984 14: 111-118; doi:10.1093/jac/14.suppl_A.111 [Abstract] [PDF] [Request Permissions]  

Section IV. Future Prospects Back

R. T. Walker
Prospects for the design of new antiviral molecules: a chemist's view
J. Antimicrob. Chemother. 1984 14: 119-126; doi:10.1093/jac/14.suppl_A.119 [Abstract] [PDF] [Request Permissions]  

George J. Galasso
Future prospects for antiviral agents and new approaches
J. Antimicrob. Chemother. 1984 14: 127-136; doi:10.1093/jac/14.suppl_A.127 [PDF] [Request Permissions]  

Index Back

Index
J. Antimicrob. Chemother. 1984 14: 137-138; doi:10.1093/jac/14.suppl_A.137 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.